PEAK6 Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,000
Closed -$206K 4534
2017
Q4
$206K Buy
+5,000
New +$175K ﹤0.01% 3141
2017
Q1
Sell
-79,500
Closed -$1.97M 4536
2016
Q4
$1.97M Buy
79,500
+52,500
+194% +$1.19M 0.01% 1325
2016
Q3
$609K Buy
27,000
+13,800
+105% +$324K ﹤0.01% 2176
2016
Q2
$315K Sell
13,200
-5,700
-30% -$137K ﹤0.01% 2769
2016
Q1
$449K Sell
18,900
-48,300
-72% -$1.18M ﹤0.01% 2373
2015
Q4
$1.87M Buy
67,200
+59,300
+751% +$1.49M 0.01% 1401
2015
Q3
$163K Buy
+7,900
New +$200K ﹤0.01% 3913

Other funds holding GMED

PEAK6 Group's GMED Position: Q1 2018 in Review

PEAK6 Group sold out of Globus Medical (GMED) in Q1 2018, closing a stake of 102,817 shares — an estimated $4.23M sold.

PEAK6 Group first reported a position in GMED in Q3 2016 and held it in 3 quarters. The position peaked at $4.23M in Q4 2017. 279 funds tracked by Wall St. Rank hold GMED as of Q1 2018.

  • PEAK6 Group reported no remaining Globus Medical position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 102,817 Globus Medical shares in Q1 2018, an estimated $4.23M.
  • PEAK6 Group first reported a position in Globus Medical in Q3 2016 and held it in 3 quarters.
  • PEAK6 Group's Globus Medical position peaked at $4.23M in Q4 2017.
  • 279 funds tracked by Wall St. Rank held Globus Medical as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.